White label ELPA - ClinicalTrials.eu

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Not recruiting

3 1
Investigated drugs:
- Astegolimab
+10
Study on the Effectiveness of Mistletoe Extract and Mitomycin in Patients with Superficial Bladder Cancer

Not recruiting

3 1 1 1
Investigated drugs:
- Extract Of Fresh Ash Mistletoe Herb
- Mitomycin
Study on Patiromer and Placebo for Managing Hyperkalemia in Non-Dialysis Patients with Chronic Kidney Disease Stages IIIB to V

Not recruiting

3 1 1
Investigated diseases:
- Hyperkalaemia
Investigated drugs:
Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

Not recruiting

3 1 1
Investigated diseases:
- Focal segmental glomerulosclerosis
Investigated drugs:
+1
Study Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Lenvatinib
- Pembrolizumab
+1
Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
Study on the Effect and Safety of Phenylephrine Hydrochloride, Tropicamide, and Lidocaine Hydrochloride in Children with Cataracts Undergoing Surgery

Not recruiting

3 1 1 1
Investigated diseases:
- Cataract
Investigated drugs:
Study of Orismilast for Treating Moderate to Severe Ulcerative Colitis in Adults

Not recruiting

2 1 1
Investigated drugs:
- Orismilast
Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Not recruiting

3 1 1
Investigated diseases:
- Ovarian epithelial cancer
Investigated drugs:
+2
Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Not recruiting

3 1 1
Investigated diseases:
- Cardiovascular disorder
Investigated drugs:
+16

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies